|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Deletion of amino acods Asp487-Ser488-Phe489 in human cytochrome P450c17 cause severe 17 α-hydroxylase deficency显示文摘 | Fardella CE Lin HZ Mahachoklertwattna P | 1993 | J Clin Endocrinol Metab1993，77，： | 1 |
| 2 | Primary aldosteronism in essential hypertensives:prevalence,biochemical profile and molecular biology显示文摘 | Fardella CE Mosso L Gomez-Sanchez C | 2000 | J Clin Endocrinol Metab2000，85，5： | 1 |
| 3 | Genetic variation in P450cⅡAS in chilean patients with low rennin hypertension显示文摘 | Fardella CE Rodrigue ZI-I Montero J | 1996 | J Clin Endocrinol Metab1996，81，： | 1 |
| 4 | Primary hyper-aldosteronism in essential hypertensives: prevalence, biochemicalprofile, and molecular biology显示文摘 | Fardella CE Mosso L Gomez-Sanchez C | 2000 | J Clin Endocrinol Metab2000，85，5： | 1 |
| 5 | Epige- netics and arterial hypertension: the challenge of emerging evidence显示文摘 | Friso S Carvajal CA Fardella CE | 2015 | Transl Res2015，165，1： | 1 |
| 6 | Deletion of amino acids Asp487-Ser488-Phe489 in human cytochrome P450c17 causes severe 17 alpha-hydroxylase deficiency显示文摘 | Fardella CE Zhang LH Mahachoklertwattana P | 1993 | J Clin Endocrinol Metab1993，77，2： | 1 |
| 7 | Primary hyperaldosteronism in essential hypertensives:prevalence, biochemical profile, and molecular biology显示文摘 | Fardella CE Mosso L Gome z-Sanchez C | 2000 | J Clin Endocrinol Metab2000，85，5： | 1 |
| 8 | Deletion of amino acids Asp487-Ser488-Phe489 in human cytochrome P450c17 causes severe 17 alpha-hydroxylase deficiency显示文摘 | Zhang LH Mahachoklertwattana P | 1993 | J Clin Endocrinol Metab1993，77，2： | 1 |
| 9 | Deletion of amino acids Asp487-Ser488-Phe489 in human cytochrome P450C17 cau- ses severe 17-hydroxylase deficiency 显示文摘 | Fardella CE Lin HZ Mahachoklertwattna P | 1993 | Clin Endoerinol Metab1993，77，： | 1 |
| 10 | Primary hyperaldosteronism in essential hypertensives:prevalence,biochemical profile and molecular biology显示文摘 | Fardella CE Mosso L Gomez-Sanchez C | 2000 | Clin Endocrinol Metab2000，85，： | 1 |
| 11 | Congenital lipo id adrenal hyperplasia caused by a novel splicing mutation in the gene for the steroidogenic acute regulatory protein 显示文摘 | Gonzalez AA Reyes ML Fardella CE eta! | 2004 | J Clin Endocrinol Metab2004，89，2： | 1 |
| 12 | Genetic variation in P450c11AS in Chilean patients with low renin hypertension显示文摘 | Fardella CE Rodriguez H Montero J | 1996 | J Clin Endocrinol Metab1996，81，12： | 1 |
| 13 | 血清皮质醇和皮质素是部分11β-羟基类固醇脱氢酶2缺陷症的潜在生物标志显示文摘11β-羟基类固醇脱氢酶 2(11-beta hydroxysteroid dehydrogenase type 2 ,HSD11B2)基因的致病性变异可引起明显的盐皮质激素过量综合征(apparent mineralocorticoid excess, AME ) o然而关于携带HSD11B2基因致病性变异杂合子的受试者的表型信息很少。本研究调查血清皮质醇(cortisol,F)和皮质素(cortisone,E)的比值(F/E)和皮质素是否能有效地在这些杂合子受试者中鉴定出部分11β-HSD2缺陷症。方法:对确诊为AME的两对夫妻及其携带D223N或R213C突变的家人进行研究。同时健康对照受试者32人(13名儿童和19名成人)进行检测.以获得所有测量变量的正常参考值范围。 | Carvajal CA Tapia-Castillo A Valdivia CP Allende F Solari S Lagos CF Campino C Martinez-Aguayo A Vecchiola A Pinochet C Godoy C Iturrieta V Baudrand R Fardella CE | 2019 | 中华高血压杂志2019，27，4： | 1 |
| 14 | Primary hyperaldosteronism in essential hypertensives:prevalence,biochemical profile,and molecular biology显示文摘 | Fardella CE Mosso L Gomez-Sanchez C | 2000 | J Clin Endocrinol Metab2000，85，5： | 1 |
| 15 | Primary hyperalsosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology显示文摘 | Fardella CE Mosso L Celso GS | 2000 | J Clin Endocrinol Metab2000，85，5： | 1 |
| 16 | Genetic variation in P450c11AS in Chilean patients with low renin hypertension显示文摘 | Rodriguez H Montero J | 1996 | J Clin Endocrinol Metab1996，81，12： | 1 |
| 17 | Epigeneties and arterial hypertension: the challenge of emerging evidence显示文摘 | Friso S Carvajal CA Fardella CE | 2015 | Transl Res2015，165，1： | 1 |
| 18 | 醛固酮与肾素比值可预测非典型原发性 醛固酮增多症患者的心脏代谢紊乱情况显示文摘醛固酮与肥胖、代谢综合征(metabolic syndrome,MS)、炎症和血栓前状态有关;然而,大多数研究将这些指标与原发性醛固酮增多症(primary aldosteronism,PA)联系起来,排除了非PA的患者。本研究旨在确定在非PA人群中醛固酮、肾素或血浆醛固酮与肾素比值(plasma aldosterone to renin ratio,ARR)与代谢紊乱和炎症/血管生物标志物是否相关。方法:对275例患者(包括2种性别和青少年)进行血浆和尿醛固酮检测,并测定血浆肾素活性。在所有受试者中,MS的诊断根据美国国家胆固醇教育计划成人治疗组(adult treatment panel,ATP)第三次报告Ⅲ(ATPⅢ)来确定,并对代表肾脏、血管、炎症和盐皮质激素活性的生物标记物进行评估。 | 陈云(编译) 叶鹏(审校) Vecchiola A Fuentes CA Barros ER Martínez-Aguayo A García H Allende F Solari S Olmos R Carvajal C Tapia-Castillo A Campino C Kalergis AM Baudrand R Fardella CE | 2020 | 中华高血压杂志2020，28，4： | 1 |
| 19 | Primary hyper-aldosteronism in essential hypertensives: prevalence, biochemicalprofile, and molecular biology显示文摘 | Fardella CE Mosso L Gomez-Sanchez C | 2000 | J Clin Endocrinol Metab2000，85，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员